Rite Aid (NYSE:RAD) Wins Pharmacy Award

Rite Aid (NYSE:RAD) has won the American Pharmacists Associations Award for its
2011-12 Immunization Program. Rite Aid (NYSE:RAD) Wins Pharmacy Award Rite Aid
(NYSE:RAD) has received the American Pharmacists Associations Immunization
Champion Award. The award recognizes Rite Aid (NYSE:RAD)s Commitment to
Pharmacist-Administered Vaccines. Robert I. Thompson, Rite Aid (NYSE:RAD)
Executive Vice President of Pharmacy, said that, Rite Aid (NYSE:RAD) made a
company-wide commitment to boosting public immunization rates for flu and other
vaccine-preventable diseases. Its an honor to be recognized by our peers,
American Pharmacists Association, for our efforts. Id like to thank all Rite Aid
(NYSE:RAD) pharmacists, as well as our store and corporate support teams, for
making this valuable pharmacy service available to the communities Rite Aid
(NYSE:RAD) serves". Rite Aid (NYSE:RAD) shares were at 1.59 at the end of the
last days trading. Theres been a 37.4% change in the stock price over the past 3
months. Rite Aid (NYSE:RAD) Analyst Advice Consensus Opinion: Moderate Sell Mean
recommendation: 3.33 (1=Strong Buy, 5=Strong Sell) 3 Months Ago: 3.33 Zacks
Rank: 2 out of 11 in the industry